Hepatitis D clinical trials
The registry lists 82 studies for Hepatitis D across more than 10 countries. 23 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-24.
Status
- Completed
- 34
- Recruiting
- 17
- Active, not recruiting
- 9
- Status unknown
- 8
- Not yet recruiting
- 6
- Terminated
- 4
Phase
- Phase 2
- 27
- Phase 3
- 12
- Phase 1
- 2
- Phase 4
- 1
Where
- France
- 15
- Italy
- 14
- United States
- 14
- Romania
- 13
- Germany
- 12
- Pakistan
- 8
Who runs them
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (7) · Eiger BioPharmaceuticals (6) · Hoffmann-La Roche (4) · Vir Biotechnology, Inc. (4) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico (4) · National Taiwan University Hospital (3) · Replicor Inc. (3) · Mirum Pharmaceuticals, Inc. (3)
Studies
Recruiting first, then most recently updated. Showing 50 of 82 — search for more.
- Evaluation of Patients With Liver DiseaseRecruitingNCT000019711 country
- A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)RecruitingNCT07200908Phase 311 countries
- A Phase III Study to Evaluate the Efficacy and Safety of Libevitug in Participants With Chronic HDV Infection (D-clear Study)RecruitingNCT07499544Phase 33 countries
- Hepatitis B Infection SurveillanceNot yet recruitingNCT077271871 country
- "Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.RecruitingNCT073170111 country
- Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+DRecruitingNCT074918481 country
- "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".RecruitingNCT046909721 country
- Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide TreatmentRecruitingNCT065044851 country
- Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in FranceNot yet recruitingNCT07038863Not applicable1 country
- DELTA DESCRIBE: the French Collaborative ProjectRecruitingNCT059360731 country
- HDV Screening StudyRecruitingNCT068898051 country
- National Cohort of Patients Co-infected with Hepatitis B and Delta VirusesRecruitingNCT041662661 country
- Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)RecruitingNCT061222851 country
- MIGrant Reflex Test HDV (MIGRED) ProjectNot yet recruitingNCT06539052
- Determination of New Detection and Quantification Thresholds for Serological and Molecular Tests for Hepatitis Delta Virus (HDV) Using Capillary Blood on Blotting Paper (DBS)Not yet recruitingNCT06649396Not applicable1 country
- Find HDV and Determine Its Status in TurkeyRecruitingNCT062485801 country
- Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated CirrhosisRecruitingNCT063978591 country
- HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV CoinfectionRecruitingNCT062645831 country
- Standardising Care for Hepatitis Delta in the NetherlandsRecruitingNCT059037421 country
- Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D PatientsRecruitingNCT060510451 country
- HEllenic Multicenter ReAl-life CLInical Study for Bulevirtide Therapy in Chronic Hepatitis D: HERACLIS-BLVRecruitingNCT059280001 country
- A Study to Compare P1101 Plus TAF With or Without UDCA in Patients With HBV and HDV Co-InfectionNot yet recruitingNCT05467553Phase 21 country
- Registry-based Study in Patients With Hepatitis D Virus (HDV) Infection in ChinaNot yet recruitingNCT054510821 country
- A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With BulevirtideActive, not recruitingNCT07128550Phase 37 countries
- Liver Fibrosis in Zambian HIV-HBV Co-infected PatientsCompletedNCT023446801 country
- A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)Active, not recruitingNCT07298330Phase 310 countries
- SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.Active, not recruitingNCT05461170Phase 29 countries
- Chronic Hepatitis B Virus Infection in ZambiaCompletedNCT031588181 country
- Once Daily Dosing of Lonafarnib Co-administered With Ritonavir for Treatment of Chronic Hepatitis D Virus InfectionCompletedNCT05229991Phase 33 countries
- A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV InfectionActive, not recruitingNCT06903338Phase 310 countries
- A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta InfectionActive, not recruitingNCT06907290Phase 2/312 countries
- A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV InfectionActive, not recruitingNCT07142811Phase 211 countries
- Study of ARC-520 With or Without Other Drugs Used in the Treatment of Chronic Chronic Hepatitis B Virus (HBV)TerminatedNCT02577029Phase 28 countries
- A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis DActive, not recruitingNCT06505928Phase 21 country
- A Study to Assess the Safety, Tolerability and Pharmacokinetics of ABI-6250 in Healthy ParticipantsCompletedNCT06740474Phase 11 country
- Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)Active, not recruitingNCT048637031 country
- Incidence of Viral Hepatitis D Relapses Upon Discontinuation of Bulevirtide in Patients With Chronic Hepatitis D and Negative HDV RNACompletedNCT061214271 country
- Replicor Compassionate Access ProgramNo longer availableNCT056835485 countries
- Burden of Hepatitis D Virus (HDV) Infection in ItalyCompletedNCT057230681 country
- Study to Assess Efficacy and Safety of Bulevirtide in Combination With Pegylated Interferon Alfa-2a in Participants With Chronic Hepatitis Delta (CHD)CompletedNCT03852433Phase 24 countries
- Evaluation of the Effectiveness of the Complex of Carnitine Orotate and Biphenyl Dimethyl Dicarboxylate in the Adjuvant Therapy of Chronic Hepatitis D in Real Clinical Practice: a Prospective Cohort StudyWithdrawnNCT060681401 country
- Peginterferon Lambda and Lonafarnib Boosted With Ritonavir 48-Week Combination Therapy for Delta HepatitisWithdrawnNCT05953545Phase 21 country
- Study of Hepalatide in Chronic Hepatitis D(CHD) PatientsCompletedNCT05827146Phase 22 countries
- Prevalence and Clinical Characterization of Hepatitis D Virus (HDV) Infection Among Sudanese Patients With Hepatitis B VirusCompletedNCT063604841 country
- A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With Chronic Hepatitis B and Hepatitis D Co-infectionTerminatedNCT05674448Phase 21 country
- Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDVActive, not recruitingNCT05070364Phase 312 countries
- Efficacy and Safety of Bulevirtide (BLV) Therapy in HDV Chronic Hepatitis (CHD) in ItalyCompletedNCT059623071 country
- Titrating-Dose of Lonafarnib in Combination With RitonavirCompletedNCT02527707Phase 2
- Epidemiology of Hepatitis B, C and D and HIV Along the Maroni River Bordering French Guiana and Suriname (MaHeVi)CompletedNCT050029072 countries
- Study of the Efficacy and Safety of Lonafarnib / Ritonavir With and Without Pegylated Interferon -Alfa-2aCompletedNCT03719313Phase 322 countries